Success Metrics

Clinical Success Rate
89.5%

Based on 17 completed trials

Completion Rate
89%(17/19)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(11%)

Phase Distribution

Ph not_applicable
1
5%
Ph phase_4
8
42%
Ph phase_2
3
16%
Ph phase_3
7
37%

Phase Distribution

0

Early Stage

3

Mid Stage

15

Late Stage

Phase Distribution19 total trials
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
7(36.8%)
Phase 4Post-market surveillance
8(42.1%)
N/ANon-phased studies
1(5.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.5%

17 of 19 finished

Non-Completion Rate

10.5%

2 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(17)
Terminated(2)

Detailed Status

Completed17
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (15.8%)
Phase 37 (36.8%)
Phase 48 (42.1%)
N/A1 (5.3%)

Trials by Status

terminated211%
completed1789%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT00650624Phase 2

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

Completed
NCT00653354Phase 3

Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery

Completed
NCT00648258Phase 3

A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

Completed
NCT00649415Phase 4

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

Completed
NCT00657449Phase 4

A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain

Terminated
NCT00260325Phase 4

Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers

Completed
NCT00115752Phase 2

Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain

Completed
NCT00021996Not Applicable

Valdecoxib in Treating Chronic Pain in Cancer Patients

Completed
NCT00419549Phase 2

Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)

Terminated
NCT00650598Phase 4

A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction

Completed
NCT00122096Phase 4

Perioperative Inflammation and Cyclooxygenase 2 (COX-2)

Completed
NCT00650455Phase 4

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Completed
NCT00650039Phase 3

Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction

Completed
NCT00683137Phase 3

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

Completed
NCT00671320Phase 4

A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle

Completed
NCT00647829Phase 3

A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat

Completed
NCT00661635Phase 3

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

Completed
NCT00652808Phase 3

Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee

Completed
NCT00649610Phase 4

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19